Contrary to what might be expected, a financial incentive to boost uptake of diabetic retinopathy screening was found to deter invitees from attending. Medscape Medical News
Tag: Diabetes & Endocrinology
‘One-Stop Shop’ for Diabetic Neuropathy Along With Eye Screening
While diabetic patients are waiting for their eye drops to take effect at retinopathy screening, they could quickly be assessed for early diabetic neuropathy with new devices, at a one-stop shop. Medscape Medical News
Blindness Due to Diabetic Retinopathy Surges Worldwide
The percentage of blindness and visual impairment attributable to diabetic retinopathy was lower in low-income regions with younger populations and higher in high-income parts of the world. Medscape Medical News
Diabetic Retinopathy Risk Drops With Diet Rich in Marine PUFAs
At least two meals per week containing oily fish, rich in omega-3 fatty acids, seems enough to cut the risk by almost half in people with type 2 diabetes, suggests a post hoc analysis of a major trial. Medscape Medical News
Better Than Drugs: A Diabetes Prevention Program That Works
Matt Longjohn, national health officer of the YMCA, describes the very successful diabetes prevention programs administered through the YMCA and deemed reimbursable by CMS. Medscape Family Medicine
USPSTF Diabetes Screening Recommendations Are Cost-effective
The guideline means more people will be screened but it will still be of value, said an economist. Medscape Medical News
Following in My Footsteps: A Dad Reflects on His MD Kids
For Father’s Day, a physician reflects on what it’s like to have raised two future physicians.
Medscape Diabetes & Endocrinology
Obesity Surgery in Diabetics May Mean Less Eye and Nerve Damage
Patients whose type 2 diabetes improves after bariatric surgery may also be less likely to suffer microvascular complications, a U.S. study suggests. Reuters Health Information
Eye Benefits Last 4 Years Past Tight Glucose Control: ACCORDION
In this ACCORD follow-up in patients with longstanding type 2 diabetes plus cardiovascular disease, intensive glycemic control reduced the risk of retinopathy progression years later, in a “legacy effect.”
Medscape Medical News
Eye and Kidney Damage in Diabetes Tied to Heart Problems
Diabetes complications like eye, kidney and nerve damage can all increase the odds of hospitalizations and death from heart problems, a recent study suggests. Reuters Health Information
Vitamin D Deficiency Linked to Diabetic Retinopathy
A systematic review and meta-analysis find association, but the mechanism isn’t clear, and no randomized clinical trials of supplementation have been conducted as yet. Medscape Medical News
Persistent Diabetic Macular Edema: Converting Eyes to Aflibercept
In patients with persistent diabetic macular edema, switching from an older VEGF inhibitor to a newer one may improve outcomes. Conversion to aflibercept may now be another option. Medscape Medical News
Diabetes Linked to Lower Life Expectancy, More Disability
An Australian study suggests women and men with diabetes have lower life expectancy and more years of disability than nondiabetics; women with diabetes spend the most time living with disability. Medscape Medical News
Interplay Between Glycemic Control, Lipids and Diabetic Eye Disease
New data from the VA Diabetes Trial (VADT) reveal some “interesting interactions” between intensive glucose control and lipids in relationship to progression of diabetic retinopathy, researchers say.
Reuters Health Information
Diabetic Retinopathy Common in Hospitalized Diabetics
Close to half of hospitalized diabetics have diabetic retinopathy and the condition has not been previously diagnosed in about a quarter, according to a small study from Pennsylvania. Reuters Health Information
New Scan for Diabetic Eye Disease Is Better, but at a Cost
Telescreening trial in remote areas of the Indian Health Service finds that new ultrawide field imaging may cut the number of people referred unnecessarily for diabetic retinopathy follow-up, but at a price. Medscape Medical News
Aflibercept Best in Diabetics With Bad Baseline Vision?
Final results from a trial comparing aflibercept, bevacizumab, and ranibizumab in diabetic macular edema confirm all three drugs are similar, but aflibercept is best in those with worse baseline vision, says lead researcher. Medscape Medical News
Antithyroid Treatment as Effective as RAI for Graves Relapse
Low-dose methimazole treatment is an option for relapsed Grave’s disease patients and even showed greater improvement in Graves’ ophthalmopathy compared with radioiodine treatment. Medscape Medical News
ACCORDION CV Mortality Drops, Eye Benefits Remain in Follow-up
New data from ACCORD long-term follow-up study: cardiovascular mortality risk with tight glycemic control attenuates, retinopathy benefit remains, and brain function unaffected. Medscape Medical News
Diabetic Vision Loss Medication May Promote Return to Driving
After a year of treatment with the drug ranibizumab (Lucentis), some people with vision loss due to diabetes regain their confidence to drive and have vision good enough to do so, according to a new study. Reuters Health Information